Skip to main content
Premium Trial:

Request an Annual Quote

Dx Focus: LabMD to Distribute Mitomics' Prostate Test; Lab21's NSCLC Companion Dx Test


Mitomics said this week that it has signed a non-exclusive agreement with LabMD to market its Prostate Core Mitomic Test in the US.

LabMD, an Atlanta-based clinical pathology laboratory, will distribute the test to its urology customers for patients with suspected prostate cancer who have a negative initial biopsy outcome.

PCMT is a PCR-based mitochondrial DNA test that detects the presence of cancerous cells using previously obtained prostate biopsy tissue.

Mitomics said the test has sensitivity of 84 percent and can accurately rule out prostate cancer with a negative predictive value of 91 percent.

Lab21, a personalized medicine diagnostics firm based in Cambridge, UK, has launched an EML4-ALK companion diagnostic testing service for non-small cell lung cancer patients.

The service will offer PCR-based testing for translocations in the ALK gene associated with response to ALK inhibitor therapy.

Lab21 will perform the test in its accredited laboratories in Cambridge. The test adds to companion diagnostics that the company already offers for portfolio KRAS, EGFR, and BRAF mutation analysis.

Clinical trials have shown that NSCLC patients with translocations in the ALK gene have a better outcome when treated with an ALK inhibitor. Approximately 5 percent of NSCLC patients harbor an ALK translocation and more than 80 percent of those are with the EML4 gene, Lab21 said.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.